RESTI Registry: Spanish Registry of Primary Immune Thrombocytopenia and Other Immune Thrombocytopenia
Key facts
- Where
- A Coruña, Algeciras, Barcelona, Bilbao, Cadiz, Castellon, Córdoba, Granada, Huelva, Jaén, Jerez de la Frontera, Lleida, Lugo, Madrid, Málaga, Marbella, Osuna, Oviedo, Palma, Pamplona, Ronda, Salamanca, Santa Cruz de Tenerife, Seville, Terrassa, Torrelavega, Valencia, and Zaragoza, SpainSee the 36 sites
Where in Spain
- Complexo Hospitalario Universitario A CoruñaA Coruña, SpainContact: María del Carmen Gómez Del Castillo Solano, MDTaking people
- Hospital Universitario Punta de EuropaAlgeciras, SpainContact: Alberto Casaus Garcia, MDTaking people
- Hospital del MarBarcelona, SpainContact: Blanca Sánchez González, MDTaking people
- Hospital Vall d'HebronBarcelona, SpainContact: David Valcárcel FerreirasNot yet recruiting
- Hospital De BasurtoBilbao, SpainContact: Laura Hernández VázquezTaking people
- Hospital Puerta del MarCadiz, SpainContact: María Yera Cobo, MDTaking people
- Hospital de La PlanaCastellon, SpainContact: Silvia Bernat PabloTaking people
- Hospital Universitario Reina Sofia de CórdobaCórdoba, SpainContact: Mª Carmen Fernandez Sanchez de Mora, MDTaking people
- Hospital Universitario Virgen de las NievesGranada, SpainContact: Laura Entrena Ureña, MDTaking people
- Hospital Juan Ramon JimenezHuelva, SpainContact: Bianca Dí-az Roldan, MDTaking people
- Complejo Hospitalario de JaenJaén, SpainContact: María Nieto Hernández, MDTaking people
- Hospital Universitario De JerezJerez de la Frontera, SpainContact: Rosa María Campos Álvarez, MDTaking people
- Hospital Universitario Arnau de VilanovaLleida, SpainContact: Armando Galán, MDNot yet recruiting
- Hospital Universitario Lucus AugustiLugo, SpainContact: Alvaro Lorenzo Vizcaya, MDTaking people
- Hospital Clínico San CarlosMadrid, SpainContact: Estefanía Bolaños CalderónTaking people
- Hospital General Universitario Gregorio MarañónMadrid, SpainContact: Cristina Pascual Izquierdo, MDTaking people
- Hospital Infantil Universitario Nino JesusMadrid, SpainContact: Elena Sebastián Pérez, MDTaking people
- Hospital Universitario 12 OctubreMadrid, SpainContact: Denis Zafra Torres, MDTaking people
- Hospital Universitario La PazMadrid, SpainContact: Mª Teresa Álvarez Román, MDNot yet recruiting
- Hospital Materno Infantil de MálagaMálaga, SpainContact: Mª Rosario Prieto Bonilla, MDTaking people
- Hospital Universitario Regional de MálagaMálaga, SpainContact: Francisco José López Jaime, MDTaking people
- Hospital Universitario Virgen de la VictoriaMálaga, SpainContact: Isabel Socorro Caparrós Miranda, MDTaking people
- Hospital Universitario Costa del SolMarbella, SpainContact: Mª Esperanza Moreno Beltrán, MDTaking people
- Hospital de la MercedOsuna, SpainContact: Rocío Cardesa CabreraNot yet recruiting
- Hospital Universitario Central De AsturiasOviedo, SpainContact: Daniel Martínez Carballeira, MDTaking people
- Hospital Universitario Son EspasesPalma, SpainContact: Mariana Canaro, MDTaking people
- Hospital Universitario de NavarraPamplona, SpainContact: Montse Alvarellos Outeiro, MDTaking people
- Hospital de la Serranía de RondaRonda, SpainContact: Reyes Jiménez Bárcenas, MDTaking people
- Complejo Asistencial Universitario de SalamancaSalamanca, SpainContact: José María Bastida BermejoNot yet recruiting
- Hospital Universitario de CanariasSanta Cruz de Tenerife, SpainContact: Sunil LakhwaniTaking people
- Hospital Universitario Virgen de la MacarenaSeville, SpainContact: Gloria García-Donas Gabaldón, MDTaking people
- Hospital Universitario Virgen del RocioSeville, SpainContact: MARIA EVA MINGOT CASTELLANO, MDTaking people
- Hospital Universitario Mútua TerrassaTerrassa, SpainContact: Silvia Del Rocio Verdesoto Cozzarelli, MDNot yet recruiting
- Hospital SierrallanaTorrelavega, SpainContact: Amalia Cuesta GarcíaNot yet recruiting
- Hospital Clínico de ValenciaValencia, SpainContact: Marisa Calabuig MuñozTaking people
- Hospital Universitario Miguel ServetZaragoza, SpainContact: Gonzalo Caballero Navarro, MDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Fundación Española de Hematología y Hemoterapía
- Trial code
- NCT06919341
- Record updated
- 9 April 2025
- Original description
Primary immune thrombocytopenia (PIT), previously referred to as idiopathic thrombocytopenic purpura, is an acquired disease characterized by accelerated platelet destruction and deficient platelet production by megakaryocytes.Read full original descriptionShow less
Primary immune thrombocytopenia (PIT), previously referred to as idiopathic thrombocytopenic purpura, is an acquired disease characterized by accelerated platelet destruction and deficient platelet production by megakaryocytes.
Although the existence of PIT has been known for decades, there is no consensus on its triggering mechanisms. On the other hand, this disease presents a very heterogeneous patient profile, both in its characteristics and treatments. In this sense, the diagnosis is still made by excluding other causes of thrombocytopenia.
There is insufficient epidemiological data on the disease, a fact that is especially evident in our country. We have no data on the incidence or prevalence of this pathology in Spain.
For all these reasons, this epidemiological study has been designed to increase the available knowledge about this disease and the detailed characterization of the population of patients with ITP in Spain.
The main objective of this study is to describe the clinical, analytical and treatment characteristics of primary immune thrombocytopenia and other immune thrombocytopenia.
The study is an epidemiological, ambispective, multicenter study carried out in hospitals in Spain.
Information will be collected on the disease under study, as well as on the treatments received, using the patient's clinical history as a source document.
Inclusion: Children as young as 2 months of age and adults in follow-up since 2015 (irrespective of date of diagnosis) with the diagnostic presumption of PIT or other thrombocytopenia of probable immune origin defined as a platelet count < 100 x 109/L; Patients who have given written informed consent. In the case of deceased patients, the data will be included in the registry and the investigator will record the impossibility of collecting patient's informed consent form due to death. Only patients deceased after December 31 2015, will be included.
Exclusion: Patients who, at the investigator's discretion, do not meet the conditions for inclusion in the study.